Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-18
1997-11-25
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548204, 548206, 548236, 548333, 548405, 549313, 549318, A61K 31365, C07D30760
Patent
active
056913745
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 4302461 (1981-11-01), Cherkofsky
patent: 4427693 (1984-01-01), Haber
patent: 5207817 (1993-05-01), Kramer et al.
patent: 5344991 (1994-09-01), Reitz et al.
patent: 5393790 (1995-02-01), Reitz et al.
Dikshit, et al., Indian Journal of Chem., vol. 29B, pp. 954-960 (1990).
Lombardino, et al., Arzneim-Forsch. (Drug Res.), vol. 25, NR. 10, pp. 1629-1635 (1975).
Yang, et al., J. Chem. Soc., Chem. Commun., pp. 656-658 (1992).
Black Cameron
Grimm Erich
Leger Serge
Wang Zhaoyin
Dentz Bernard
Merck Frosst Canada Inc.
Panzer Curtis C.
Rose David L.
LandOfFree
Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107495